Outcomes of therapy vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients.

Suppr

超能文献

作者信息

Kraft Shawna, Mackler Emily, Schlickman Peter, Welch Kathy, DePestel Daryl D

出版信息

Support Care Cancer. 2012 Sep;20(9):1935-6. doi: 10.1007/s00520-012-1440-9. Epub 2012 Mar 25.

DOI:10.1007/s00520-012-1440-9

PMID:22447367

Abstract

摘要

相似文献

Outcomes of therapy vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients.

Support Care Cancer. 2012 Sep;20(9):1935-6. doi: 10.1007/s00520-012-1440-9. Epub 2012 Mar 25.

Letter to the Editor: Regarding: Kraft S, Mackler E, Schlickman P, Welch K, DePestel DD (2011) Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients. Supp Care Cancer 19;1969-1974.

Support Care Cancer. 2012 Jun;20(6):1117-8. doi: 10.1007/s00520-012-1419-6. Epub 2012 Mar 4.

Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients.治疗结果：血液科和骨髓移植患者的万古霉素耐药肠球菌菌血症。

Support Care Cancer. 2011 Dec;19(12):1969-74. doi: 10.1007/s00520-010-1038-z. Epub 2010 Nov 26.

Development of daptomycin resistance in a bone marrow transplant patient with vancomycin-resistant Enterococcus durans.

J Oncol Pharm Pract. 2006 Sep;12(3):179-81. doi: 10.1177/1078155206069165.

Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study.肠球菌血症中万古霉素耐药性和死亡率的决定因素。一项前瞻性多中心研究。

Ann Intern Med. 2001 Oct 2;135(7):484-92. doi: 10.7326/0003-4819-135-7-200110020-00007.

Impact of Enterococcal Bacteremia in Liver Transplant Recipients.肠球菌血症对肝移植受者的影响。

Transplant Proc. 2019 Oct;51(8):2766-2770. doi: 10.1016/j.transproceed.2019.02.064. Epub 2019 Sep 4.

Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.耐万古霉素肠球菌血症：粪肠球菌和屎肠球菌临床特征及结局的比较

J Microbiol Immunol Infect. 2008 Apr;41(2):124-9.

A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.一项全国性、多中心、病例对照研究，比较耐万古霉素和对万古霉素敏感的肠球菌血症的危险因素、治疗方法及预后。

Diagn Microbiol Infect Dis. 2000 Mar;36(3):145-58. doi: 10.1016/s0732-8893(99)00136-4.

Mortality due to vancomycin-resistant enterococcal bacteremia versus vancomycin-susceptible enterococcal bacteremia: an ecological analysis.耐万古霉素肠球菌血症与万古霉素敏感肠球菌血症导致的死亡率：一项生态学分析。

Clin Infect Dis. 2005 Nov 15;41(10):1541-2. doi: 10.1086/497376.

Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia.万古霉素耐药和敏感肠球菌菌血症的不同危险因素。

Clin Microbiol Infect. 2012 Apr;18(4):388-94. doi: 10.1111/j.1469-0691.2011.03591.x. Epub 2011 Aug 16.

引用本文的文献

Impact on Public Health of the Spread of High-Level Resistance to Gentamicin and Vancomycin in Enterococci.肠球菌对庆大霉素和万古霉素高水平耐药性传播对公共卫生的影响

Front Microbiol. 2018 Dec 18;9:3073. doi: 10.3389/fmicb.2018.03073. eCollection 2018.

Vancomycin-resistant Enterococcus faecium Bacteremia in a tertiary care hospital: epidemiology, antimicrobial susceptibility, and outcome.三级医疗中心医院耐万古霉素屎肠球菌菌血症：流行病学、抗菌药物敏感性及转归

Biomed Res Int. 2014;2014:958469. doi: 10.1155/2014/958469. Epub 2014 Mar 5.

Treatment considerations in vancomycin-resistant enterococcal bacteremia: daptomycin or linezolid? A review.万古霉素耐药肠球菌菌血症的治疗注意事项：达托霉素还是利奈唑胺？综述。

Int J Clin Pharm. 2013 Oct;35(5):697-703. doi: 10.1007/s11096-013-9825-5. Epub 2013 Jul 27.

本文引用的文献

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.抗菌药物在肿瘤中性粒细胞减少患者应用的临床实践指南：美国传染病学会 2010 年更新版。

Clin Infect Dis. 2011 Feb 15;52(4):e56-93. doi: 10.1093/cid/cir073.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验